Protein Kinase C (PKC) is a family of serine/threomine enzymes involved with directing receptor activated signaling events of cellular growth and differentiation. PKC alpha, a lipid and calcium dependent PKC isoform is important in normal cellular functions and as well as disease. We plan to explore and discover conformational probes specific to PKC alpha protein. Phage display peptide libraries will be employed as tools to explore the entire PKC alpha protein. The experiments will be performed in the absence and presence of substrates and lipid activators. The identity of the binding peptides will be determined by DNA sequencing and confirmed with synthetic peptides. In Phase II a high throughput screen will be developed using peptide and PKC alpha. Seven other PKC enzymes will be explored for selective molecular recognition sites and screens developed for drug discovery.

Proposed Commercial Applications

The work is directed toward identification of unique relevant binding sites on PKC alpha protein for therapeutic intervention. Technology improvements in assay design and screening throughput will rest in enhancement of the drug discovery process.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43CA081898-01
Application #
2869185
Study Section
Special Emphasis Panel (ZRG1-SSS-2 (01))
Program Officer
Lees, Robert
Project Start
1999-04-05
Project End
2000-09-30
Budget Start
1999-04-05
Budget End
2000-09-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Novalon Pharmaceutical Corporation
Department
Type
DUNS #
City
Durham
State
NC
Country
United States
Zip Code
27703
Ashraf, S S; Anderson, E; Duke, K et al. (2003) Identification and characterization of peptide probes directed against PKCalpha conformations. J Pept Res 61:263-73